Annual Revenue
$277.25M$44.96M+19.36%
Summary
- Current Value
- As of today, DVAX annual revenue is $277.25M, up +19.36% on
- Historical Performance
- DVAX annual revenue is down -36.56% over the past 3 years, and up +687.21% over the past 5 years
- All-Time High Comparison
- DVAX annual revenue is currently -61.64% below its historical high of $722.68M set on
- 3-Year Low Comparison
- DVAX annual revenue is +19.36% above its 3-year low of $232.28M reached on
- Sector Comparison
- DVAX annual revenue is higher than 76.26% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate DVAX annual revenue at $338.75M, +22.18% higher than the current value
- Upcoming Earnings
- The next annual earnings release for DVAX is on
Revenue Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Revenue | $277.25M | +19.4% | -36.6% | +687.2% | +587.6% | |
| Quarterly Revenue | $94.88M | +17.7% | -43.4% | +607.3% | +714.5% | |
| TTM Revenue | $330.51M | +26.7% | -54.9% | +779.7% | +1256.1% | |
| Price | $15.41 | +22.1% | +50.0% | +208.8% | -52.9% | |
| Annual EPS | $0.20 | +512.9% | -62.2% | +109.5% | +102.7% | |
| PE Ratio | - | – | – | – | – | |
| Annual Gross Profit | $227.80M | +25.1% | -13.5% | +2254.9% | +100.0% | |
| Annual Net Income | $27.31M | +527.4% | -62.1% | +117.9% | +280.5% | |
| Annual EBITDA | $3.93M | +114.7% | -97.2% | +104.0% | +132.0% | |
| Annual EBIT | -$4.12M | +87.9% | -103.1% | +96.5% | +72.7% |
Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $722.68M | N/A | -61.6% |
| 5Y | $722.68M | -61.6% | |
| All | $722.68M | -61.6% |
Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $232.28M | +19.4% | |
| 5Y | $46.55M | N/A | +495.6% |
| All | $327.00K | >+9999.0% |
Revenue Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $229.42M | $232.28M | +1.25% | |
| $277.91M | $277.25M | -0.24% | |
| $338.75M | N/A | +22.18% | |
| $392.42M | N/A | +41.54% |
🔒 Log In To Unlock Full Data
Revenue History
FAQ
What is the current annual revenue of DVAX?
As of today, DVAX annual revenue is $277.25M
What is 1-year change in DVAX annual revenue?
DVAX annual revenue is up +19.36% year-over-year
What is 3-year change in DVAX annual revenue?
DVAX annual revenue is down -36.56% over the past 3 years
How far is DVAX annual revenue from its all-time high?
DVAX annual revenue is currently -61.64% below its historical high of $722.68M set on December 31, 2022
How does DVAX annual revenue rank versus sector peers?
DVAX annual revenue is higher than 76.26% of companies in Healthcare sector
How does the analyst estimate for DVAX annual revenue compare to its current value?
Analysts estimate DVAX annual revenue at $338.75M, +22.18% higher than the current value
When is DVAX next annual earnings release?
The next annual earnings release for DVAX is on
Quarterly Revenue
$94.88M$566.00K-0.59%
Summary
- Current Value
- As of today, DVAX quarterly revenue is $94.88M, down -0.59% on
- Historical Performance
- DVAX quarterly revenue is up +17.67% year-over-year, and down -43.44% over the past 3 years
- All-Time High Comparison
- DVAX quarterly revenue is currently -63.01% below its historical high of $256.46M set on
- 3-Year Low Comparison
- DVAX quarterly revenue is +102.19% above its 3-year low of $46.93M reached on
- Sector Comparison
- DVAX quarterly revenue is higher than 76.43% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate DVAX quarterly revenue at $80.26M, -15.40% lower than the current value
- Upcoming Earnings
- The next earnings release for DVAX is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Revenue | $94.88M | -0.6% | +17.7% | -43.4% | +607.3% | |
| Annual Revenue | $277.25M | – | +19.4% | -36.6% | +687.2% | |
| TTM Revenue | $330.51M | +4.5% | +26.7% | -54.9% | +779.7% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| Quarterly EPS | $0.21 | +52.5% | +81.6% | -52.0% | +237.2% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Gross Profit | $80.47M | -1.1% | +19.1% | -24.4% | +757.6% | |
| Quarterly Net Income | $26.93M | +43.8% | +53.0% | -57.8% | +511.8% | |
| Quarterly EBIT | $21.27M | +47.4% | +111.0% | -65.6% | +206.6% | |
| Quarterly EBITDA | $23.37M | +41.9% | +92.5% | -63.1% | +228.3% |
Quarterly Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $95.44M | -0.6% | |
| 3Y | $184.49M | N/A | -48.6% |
| 5Y | $256.46M | -63.0% | |
| All | $256.46M | -63.0% |
Quarterly Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $68.16M | +39.2% | |
| 3Y | $46.93M | +102.2% | |
| 5Y | $19.55M | N/A | +385.3% |
| All | $0.00 | N/A |
Quarterly Revenue Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $86.66M | $95.44M | +10.13% | |
| $94.00M | $94.88M | +0.93% | |
| $80.26M | N/A | -15.40% | |
| $84.68M | N/A | -10.75% |
🔒 Log In To Unlock Full Data
Quarterly Revenue History
FAQ
What is the current quarterly revenue of DVAX?
As of today, DVAX quarterly revenue is $94.88M
What is DVAX quarterly revenue most recent change?
DVAX quarterly revenue was down -0.59% on September 30, 2025
What is 1-year change in DVAX quarterly revenue?
DVAX quarterly revenue is up +17.67% year-over-year
How far is DVAX quarterly revenue from its all-time high?
DVAX quarterly revenue is currently -63.01% below its historical high of $256.46M set on June 30, 2022
How does DVAX quarterly revenue rank versus sector peers?
DVAX quarterly revenue is higher than 76.43% of companies in Healthcare sector
How does the analyst estimate for DVAX quarterly revenue compare to its current value?
Analysts estimate DVAX quarterly revenue at $80.26M, -15.40% lower than the current value
When is DVAX next earnings release?
The next earnings release for DVAX is on
TTM Revenue
$330.51M$14.25M+4.50%
Summary
- Current Value
- As of today, DVAX TTM revenue is $330.51M, up +4.50% on
- Historical Performance
- DVAX TTM revenue is up +26.73% year-over-year, and down -54.93% over the past 3 years
- All-Time High Comparison
- DVAX TTM revenue is currently -54.93% below its historical high of $733.26M set on
- 3-Year Low Comparison
- DVAX TTM revenue is +42.29% above its 3-year low of $232.28M reached on
- Sector Comparison
- DVAX TTM revenue is higher than 76.16% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate DVAX TTM revenue at $338.74M, +2.49% higher than the current value
- Upcoming Earnings
- The next earnings release for DVAX is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Revenue | $330.51M | +4.5% | +26.7% | -54.9% | +779.7% | |
| Annual Revenue | $277.25M | – | +19.4% | -36.6% | +687.2% | |
| Quarterly Revenue | $94.88M | -0.6% | +17.7% | -43.4% | +607.3% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| TTM EPS | -$0.38 | +19.5% | -393.3% | -116.7% | +69.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Gross Profit | $274.90M | +4.9% | +27.2% | -42.1% | +1191.5% | |
| TTM Net Income | -$43.40M | +17.7% | -311.9% | -113.5% | +55.0% | |
| TTM EBITDA | $18.68M | +150.8% | +3665.7% | -94.0% | +124.6% | |
| TTM EBIT | $10.44M | +1489.9% | +240.2% | -96.5% | +111.9% |
TTM Revenue Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $330.51M | at high | |
| 3Y | $722.68M | N/A | -54.3% |
| 5Y | $733.26M | -54.9% | |
| All | $733.26M | -54.9% |
TTM Revenue Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $277.25M | N/A | +19.2% |
| 3Y | $232.28M | +42.3% | |
| 5Y | $46.55M | N/A | +610.0% |
| All | $0.00 | N/A |
TTM Revenue History
FAQ
What is the current TTM revenue of DVAX?
As of today, DVAX TTM revenue is $330.51M
What is DVAX TTM revenue most recent change?
DVAX TTM revenue was up +4.50% on September 30, 2025
What is 1-year change in DVAX TTM revenue?
DVAX TTM revenue is up +26.73% year-over-year
How far is DVAX TTM revenue from its all-time high?
DVAX TTM revenue is currently -54.93% below its historical high of $733.26M set on September 30, 2022
How does DVAX TTM revenue rank versus sector peers?
DVAX TTM revenue is higher than 76.16% of companies in Healthcare sector
How does the analyst estimate for DVAX TTM revenue compare to its current value?
Analysts estimate DVAX TTM revenue at $338.74M, +2.49% higher than the current value
When is DVAX next earnings release?
The next earnings release for DVAX is on
Data Sources & References
- DVAX Official Website www.dynavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1029142/000162828025049536/0001628280-25-049536-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1029142/000102914225000049/0001029142-25-000049-index.htm
- DVAX Profile on Yahoo Finance finance.yahoo.com/quote/DVAX
- DVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dvax